PawEnergia™

The Breakthrough of RYR, with Proven Clinical Trials and over 130 Publications for Metabolic Health

# 0

Market leadership in Taiwan red yeast rice and probiotic markets

0 +

R&D Personnel Team

Top

Leadership team with proven track record of driving success globally

Top

Leadership team with proven track record of driving success globally

PawEnergia™

ANKASCIN 568-R is extracted from fermented products of patented functional red yeast strain (Monascus purpureus NTU 568). Unlike conventional manual fermentation with derivative quality instability, this premium ingredient is the only red yeast fermented extract manufactured using an exclusive automated solid state fermentation technique. ANKASCIN 568-R is FREE of risky lovastatin/monacolin K but contains high levels of another two new active compounds (Monascin and Ankaflavin). Safety and functions have been verified through plenty of animal and clinical studies. In 2015, this ingredient was honorably reviewed and accepted by the US FDA as a NEW DIETARY INGREDIENT (NDI), which made it the only eligible red yeast ingredient on the US market that could legally apply claims and clearly specify the contents of active compounds. Therefore, it is greatly suitable for formulation of dietary supplements and fortified foods.

What We Make

Product Description

Strain Characteristics

Monascus purpureus NTU 568 is a patented functional red yeast strain isolated and studied for more than ten years by the research team of Professor Tzu-Ming Pan from National Taiwan University. Its fermented products contain high levels of two active compounds: Monascin and Ankaflavin. Science basis is perfectly supported by more than 120 related SCI publications, including a large number of animal and clinical studies verifying its effects on regulation of blood lipids, blood glucose, blood pressure, prevention and treatment of Alzheimer’s Disease, etc. It was also certified with plenty of patents from the USA, EU, Canada, Japan, Australia, China, Korea, Singapore, Taiwan, etc.

Item
Description

Active Compound Contents

Monascin ≥ 28 mg/g
Ankaflavin ≥ 9 mg/g

Daily Dosage

110 mg or 220 mg (per US FDA NDI acknowledgment)

Appearance

Red powder

Package

2 kg / aluminum foil bag

Storage & Shelf Life

2 years sealed at 25°C

Safety Tests

  • Conducted by QPS Taiwan
  • 13-week oral toxicity in rats
  • Ames test

  • In vitro chromosome aberration (CHO cells)
  • Micronucleus assay (mice)
  • Microbiological safety: strict internal standards
  • Vegetarian & free of all major food allergens

Special Status

US FDA New Dietary Ingredient (NDI) approved (Report #1071: fda_report001)

Patents & Research

Patents granted in USA, EU, Canada, Japan, Australia, China, Taiwan, Singapore, Korea

Scientific Support

Backed by 120+ SCI publications including animal and clinical studies

What We Make

Ingredient Information

Alleviation of metabolic syndrome by monascin and ankaflavin: the perspective of Monascus functional foods

Food Funct. 2017 Jun 1;8(6):2102-2109.

Alleviation of metabolic syndrome by monascin and ankaflavin: the perspective of Monascus functional foods

Food Funct. 2017 Jun 1;8(6):2102-2109.

Alleviation of metabolic syndrome by monascin and ankaflavin: the perspective of Monascus functional foods

Food Funct. 2017 Jun 1;8(6):2102-2109.
What We’ve Earned

International Certificate and Patents

Certificate

FDA NDI (#1071)

Assisting US USP Monograph

Halal Certification

Taiwan's Health Food Certificate

Patents

Taiwan's Health Food Certificate

NFSA of Egypt

Italian Food supplement (137602, 137372)

Health Canada NPN (80091703, 80125942)

Malaysia MAL (MAL20021445T, MAL07031236T)